利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

392 条记录 (耗时 0.045 秒)

    Gmg-2 polynucleotides and polypeptides and uses thereof
    3.
    发明申请
    Gmg-2 polynucleotides and polypeptides and uses thereof 审中-公开
    Gmg-2多核苷酸和多肽及其用途

    公开(公告)号：US20060293225A1

    公开(公告)日：2006-12-28

    申请号：US10484707

    申请日：2002-07-25

    申请人： Deno Dialynas ,  John Lucas ,  Aaron Scalia ,  Hiroaki Tanaka

    发明人： Deno Dialynas ,  John Lucas ,  Aaron Scalia ,  Hiroaki Tanaka

    IPC分类号： A61K38/17

    CPC分类号： A61K38/1709 ,  C07K14/435 ,  C07K2319/00

    摘要： The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, homotrimer of GMG-2 polypeptide fragment comprising globular domain and all or part of GMG-2 collagen-like region, has been identified that has utility for reducing body mass, for maintaining weight loss, and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.

    摘要翻译： 本发明涉及肥胖研究领域。 肥胖是一个严重而广泛的公共卫生问题。 已经鉴定了包含球状结构域和全部或部分GMG-2胶原样区域的GMG-2多肽片段的同三聚物，其具有用于减少体重，用于维持体重减轻和用于治疗与肥胖有关的疾病和 疾病 这些肥胖相关的疾病和病症包括高脂血症，动脉粥样硬化，糖尿病和高血压。

    Metabolic gene polynucleotides and polypeptides and uses thereof
    4.
    发明申请
    Metabolic gene polynucleotides and polypeptides and uses thereof 失效
    代谢基因多核苷酸和多肽及其用途

    公开(公告)号：US20060247160A1

    公开(公告)日：2006-11-02

    申请号：US10466376

    申请日：2002-01-15

    申请人： Mary Ruth Erickson ,  Barbara Chicca ,  Bernard Bihain ,  Hiroaki Tanaka

    发明人： Mary Ruth Erickson ,  Barbara Chicca ,  Bernard Bihain ,  Hiroaki Tanaka

    IPC分类号： A61K38/22

    CPC分类号： A61K38/1709 ,  A01K2217/05 ,  A01K2217/075 ,  C07K14/47

    摘要： The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.

    摘要翻译： 本发明涉及代谢研究领域。 代谢紊乱，如肥胖，是一个严重而广泛的公共卫生问题。 已经鉴定出有益于治疗代谢紊乱的GMG-3，GMG-4，簇1，GMG-6A或GMG-6B多肽。 这些化合物应该有效减少体重和治疗与代谢有关的疾病和病症。 这些代谢相关的疾病和病症包括高脂血症，动脉粥样硬化，糖尿病和高血压。

    Metabolic gene polynucleotides and polypeptides and uses thereof
    7.
    发明授权
    Metabolic gene polynucleotides and polypeptides and uses thereof 失效
    代谢基因多核苷酸和多肽及其用途

    公开(公告)号：US07348406B2

    公开(公告)日：2008-03-25

    申请号：US10466376

    申请日：2002-01-15

    申请人： Mary Ruth Erickson ,  Barbara A. Chicca ,  Bernard Bihain ,  Hiroaki Tanaka

    发明人： Mary Ruth Erickson ,  Barbara A. Chicca ,  Bernard Bihain ,  Hiroaki Tanaka

    IPC分类号： C07K14/00 ,  C07K16/00 ,  A61K38/00

    CPC分类号： A61K38/1709 ,  A01K2217/05 ,  A01K2217/075 ,  C07K14/47

    摘要： The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.

    摘要翻译： 本发明涉及代谢研究领域。 代谢紊乱，如肥胖，是一个严重而广泛的公共卫生问题。 已经鉴定出有益于治疗代谢紊乱的GMG-3，GMG-4，簇1，GMG-6A或GMG-6B多肽。 这些化合物应该有效减少体重和治疗与代谢有关的疾病和病症。 这些代谢相关的疾病和病症包括高脂血症，动脉粥样硬化，糖尿病和高血压。

    Display device, display system, mobile object, display control method, and recording medium storing program code
    8.
    发明授权
    Display device, display system, mobile object, display control method, and recording medium storing program code 有权

    公开(公告)号：US10962776B2

    公开(公告)日：2021-03-30

    申请号：US16779843

    申请日：2020-02-03

    申请人： Hiroaki Tanaka ,  Toshihiro Yamashiro

    发明人： Hiroaki Tanaka ,  Toshihiro Yamashiro

    IPC分类号： G02B27/01

    摘要： A display device includes a light source; a light deflector configured to deflect light emitted from the light source to scan as scanning light in a main scanning direction and a sub-scanning direction; a screen having a scanning area to be two-dimensionally scanned with the scanning light at a predetermined cycle, the scanning area having a first area and a second area that differ in position in the sub-scanning direction; a light receiver disposed on the screen, configured to detect the light scanning in each of the first area and the second area of the screen; and a control unit configured to adjust a position of the scanning light in the scanning area according to the number of scanning lines in each of the first area and the second area.

    SEMICONDUCTOR DEVICE
    10.
    发明申请
    SEMICONDUCTOR DEVICE 审中-公开
    半导体器件

    公开(公告)号：US20150054075A1

    公开(公告)日：2015-02-26

    申请号：US14501244

    申请日：2014-09-30

    申请人： Tadahiro Ohmi ,  Hiroaki Tanaka

    发明人： Tadahiro Ohmi ,  Hiroaki Tanaka

    IPC分类号： H01L29/10 ,  H01L29/417 ,  H01L29/45 ,  H01L29/78

    CPC分类号： H01L29/1087 ,  H01L27/1203 ,  H01L29/41733 ,  H01L29/458 ,  H01L29/7816

    摘要： There is provided a semiconductor device. An n-type transistor is formed on a (551) surface of a silicon substrate. A silicide layer region in contact with a diffusion region (heavily doped region) of the n-type transistor has a thickness not more than 5 nm. A metal layer region in contact with the silicide layer has a thickness of 25 nm (inclusive) to 400 nm (inclusive). A barrier height between the silicide layer region and the diffusion region has a minimum value in this thickness relationship.

    摘要翻译： 提供了一种半导体器件。 n型晶体管形成在硅衬底的（551）表面上。 与n型晶体管的扩散区域（重掺杂区域）接触的硅化物层区域的厚度不大于5nm。 与硅化物层接触的金属层区域的厚度为25nm（含）〜400nm（含）。 硅化物层区域和扩散区域之间的势垒高度在该厚度关系中具有最小值。